AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+4.14%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$100M
AUM Growth
+$100M
(-25%)
Cap. Flow
-$37.3M
Cap. Flow
% of AUM
-37.26%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
34
Reduced
105
Closed
85
Top Buys
| 1 |
Eli Lilly
LLY
|
$4.74M |
| 2 |
UnitedHealth
UNH
|
$3.6M |
| 3 |
Johnson & Johnson
JNJ
|
$2.63M |
| 4 |
AbbVie
ABBV
|
$2.31M |
| 5 |
Thermo Fisher Scientific
TMO
|
$2.17M |
Top Sells
| 1 |
Rithm Capital
RITM
|
$4.32M |
| 2 |
Harmony Biosciences
HRMY
|
$3.88M |
| 3 |
Galapagos
GLPG
|
$3.12M |
| 4 |
EFC
Ellington Financial
EFC
|
$2.6M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.57M |
Sector Composition
| 1 | Healthcare | 54.58% |
| 2 | Real Estate | 7.4% |
| 3 | Industrials | 5.96% |
| 4 | Financials | 5.87% |
| 5 | Technology | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $4.74M | 4.73% | +6,140 | New | +$4.74M |
|
|
2
UnitedHealth
UNH
$281B
| $3.6M | 3.6% | +7,123 | New | +$3.6M |
|
|
3
Johnson & Johnson
JNJ
$427B
| $2.63M | 2.62% | +18,176 | New | +$2.63M |
|
4
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $2.39M | 2.39% | 29,172 +24,690 | +551% | +$2.02M |
|
|
5
AbbVie
ABBV
$372B
| $2.31M | 2.31% | +13,018 | New | +$2.31M |
|
6
Merck
MRK
$210B
| $2.25M | 2.24% | 22,597 -1,403 | -6% | -$140K |
|
|
7
Thermo Fisher Scientific
TMO
$186B
| $2.17M | 2.17% | +4,175 | New | +$2.17M |
|
8
AstraZeneca
AZN
$248B
| $2.08M | 2.07% | +31,685 | New | +$2.08M |
|
9
Novo Nordisk
NVO
$251B
| $2.01M | 2% | +23,334 | New | +$2.01M |
|
10
Globus Medical
GMED
$8.27B
| $2M | 2% | +24,176 | New | +$2M |
|
11
Invesco S&P 500 Pure Value ETF
RPV
$1.36B
| $1.99M | 1.99% | +22,102 | New | +$1.99M |
|
12
iShares Russell 1000 Value ETF
IWD
$63.5B
| $1.98M | 1.98% | +10,710 | New | +$1.98M |
|
13
Intuitive Surgical
ISRG
$170B
| $1.93M | 1.93% | 3,706 +2,456 | +196% | +$1.28M |
|
14
Lamar Advertising Co
LAMR
$12.9B
| $1.83M | 1.82% | +15,000 | New | +$1.83M |
|
15
Boston Scientific
BSX
$156B
| $1.67M | 1.66% | +18,667 | New | +$1.67M |
|
|
PINE
16
Alpine Income Property Trust
PINE
$216M
| $1.54M | 1.54% | +91,980 | New | +$1.54M |
|
17
Novartis
NVS
$245B
| $1.53M | 1.53% | +15,719 | New | +$1.53M |
|
18
iShares Global REIT ETF
REET
$4B
| $1.44M | 1.44% | +60,000 | New | +$1.44M |
|
19
Stereotaxis
STXS
$261M
| $1.37M | 1.37% | 600,000 | – | – |
|
20
iShares 3-7 Year Treasury Bond ETF
IEI
$16.8B
| $1.34M | 1.34% | 11,636 +8,510 | +272% | +$983K |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $1.25M | 1.25% | +3,101 | New | +$1.25M |
|
22
FLEX LNG
FLNG
$1.47B
| $1.2M | 1.2% | +52,228 | New | +$1.2M |
|
|
BFS
23
Saul Centers
BFS
$833M
| $1.16M | 1.16% | +30,000 | New | +$1.16M |
|
24
Bristol-Myers Squibb
BMY
$96B
| $1.11M | 1.11% | +19,649 | New | +$1.11M |
|
25
SoundHound AI
SOUN
$5.31B
| $1.09M | 1.09% | 55,000 -70,000 | -56% | -$1.39M |
|